Arun Menawat
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Arun Menawat
Arun Menawat is recorded as Chairman at Firefly Neuroscience, Inc. (AIFF) and CEO at Profound Medical Corp. (PROF). Firefly Neuroscience, Inc. reported in an 8-K filed August 7, 2026 that Arun Menawat was appointed Class III director, effective August 5, 2026. Firefly Neuroscience, Inc. reported in an 8-K filed April 24, 2025 that Arun Menawat was appointed chairperson and member of the Compensation Committee, member of the Audit Committee, and member of the Nominating and Corporate, effective April 18, 2025. Firefly Neuroscience, Inc. reported in an 8-K filed March 12, 2025 that Arun Menawat was appointed Chairman, effective March 10, 2025. Equibles holds 4 filed executive changes naming Arun Menawat; each is listed under recent activity with its source filing. Arun Menawat has spoken on 16 earnings calls and 1 other investor event across 1 company, most recently for Profound Medical Corp. on March 5, 2026.
“A proposal to elect Arun Menawat as the Class III director to the Board of Directors (the "Board") to serve until the annual meeting of stockholders to be held in 2029, or until his successor has been duly elected and qualified.”
“On April 18, 2025, to fill the vacancies created by DeCaprio’s departure from his board committees’ roles, the Board appointed Arun Menawat (“Menawat”) to serve as the chairperson and a member of the Compensation Committee, a member of the Audit Committee, and a member of the Nominating and Corporate Governance Committee.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-04-18–present
-
Current
Start not stated–present
-
Current
-
Start not stated–2024-12-06
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Profound Medical Corp.
Other people whose current roles at this company are on record from its filings.
- Matthew Sobczyk CFO
- Frank Baylis Board Member
Leadership on record at Firefly Neuroscience, Inc.
Other people whose current roles at this company are on record from its filings.
- Greg Lipschitz CEO, Chairman, Board Member
- Stanley A. Reese CEO, Board Member
- David Johnson Chairman
- Matthew T. Sands CFO
- Stephen Purcell CFO
- David DeCaprio COO, Board Member
- Gil Issachar CTO
- Jessica Paz Chief Accounting Officer
- Bonnie K. Wachtel Board Member
- Brian Posner Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Firefly Neuroscience, Inc. (AIFF) | — | — | — |
| 2023 | Firefly Neuroscience, Inc. (AIFF) | — | — | — |
| 2022 | Firefly Neuroscience, Inc. (AIFF) | — | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.